Elevated Serum NSE in Inoperable Non-Small-Cell Lung Carcinoma (NSCLC) Is Associated with a Better Response but Worse Prognosis
Abstract
Share and Cite
Załęska, M.; Szturmowicz, M.; Zych, J.; Roszkowska-Śliż, B.; Demkow, U.; Langfort, R.; Roszkowski-Śliż, K. Elevated Serum NSE in Inoperable Non-Small-Cell Lung Carcinoma (NSCLC) Is Associated with a Better Response but Worse Prognosis. Adv. Respir. Med. 2010, 78, 14-20. https://doi.org/10.5603/ARM.27748
Załęska M, Szturmowicz M, Zych J, Roszkowska-Śliż B, Demkow U, Langfort R, Roszkowski-Śliż K. Elevated Serum NSE in Inoperable Non-Small-Cell Lung Carcinoma (NSCLC) Is Associated with a Better Response but Worse Prognosis. Advances in Respiratory Medicine. 2010; 78(1):14-20. https://doi.org/10.5603/ARM.27748
Chicago/Turabian StyleZałęska, Monika, Monika Szturmowicz, Jacek Zych, Barbara Roszkowska-Śliż, Urszula Demkow, Renata Langfort, and Kazimierz Roszkowski-Śliż. 2010. "Elevated Serum NSE in Inoperable Non-Small-Cell Lung Carcinoma (NSCLC) Is Associated with a Better Response but Worse Prognosis" Advances in Respiratory Medicine 78, no. 1: 14-20. https://doi.org/10.5603/ARM.27748